Castermans, E.* , Baron, F.* , Willems, E., Schaaf-Lafontaine, N., Meuris, N., Gothot, A., Vanbellinghen, J.-F., Herens, C., Seidel, L., Geenen, V., Cheynier, R., & Beguin, Y. (2008). Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning. Haematologica, 93 (2), 240-7. doi:10.3324/haematol.11708 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Pirson, L.* , Baron, F.* , Meuris, N., Giet, O., Castermans, E., Greimers, R., Di Stefano, I., Gothot, A., & Beguin, Y. (2006). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice. Stem Cells, 24 (7), 1814-21. doi:10.1634/stemcells.2005-0290 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Castermans, E., Baron, F., Willems, E., Meuris, N., Schaaf-Lafontaine, N., Reynier, R., Geenen, V., & Beguin, Y. (2006). Immune reconstitution after CD8-depleted or unmanipulated peripheral blood stem cells transplantation with nonmyeloablative conditioning. Acta Clinica Belgica, 61 (2), 113. Peer Reviewed verified by ORBi |
Pirson, L., Baron, F., Meuris, N., Giet, O., Castermans, E., Greimers, R., Di Stefano, I., Gothot, A., & Beguin, Y. (2005). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDBeta2mNull [Poster presentation]. 20th general meeting of the Belgian Hematological Society, Brussels, Belgium. |
Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2004). The tyrosine kinase inhibitor Imatinib increases irradiation toxicity but does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 19th general meeting of the Belgian Hematological Society, Brussels, Belgium. |
Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7 Peer Reviewed verified by ORBi |
Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2003). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor STI571 does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 32nd annual meeting of the International Society of Experimental Hematology, Paris, France. |
Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2003). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor STI571 does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 18th general meeting of the Belgian Hematological Society, Brussels, Belgium. |
Pirson, L., Baron, F., Giet, O., Meuris, N., Bours, V., Fillet, G., Gothot, A., & Beguin, Y. (2002). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibior STI571 does not impair engraftment of human CD34+ cells into NOD/SCIDB2mNull mice [Poster presentation]. 44th annual meeting and exposition of American Society of Hematology, Philadelphia, United States. |